365 related articles for article (PubMed ID: 37457696)
1. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products.
Zhao Y; Wei S; Chen L; Zhou X; Ma X
Front Immunol; 2023; 14():1164202. PubMed ID: 37457696
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
Yang Y; He X; Rojas M; Leung PSC; Gao L
Front Immunol; 2023; 14():1184252. PubMed ID: 37325634
[TBL] [Abstract][Full Text] [Related]
3. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
4. Bile duct lesions and diminution in number of intrahepatic bile ducts in asymptomatic primary biliary cirrhosis.
Yamada S; Takezawa J; Nagamine T; Ichikawa K; Arai T; Kobayashi S
Jpn J Med; 1985 May; 24(2):109-20. PubMed ID: 4021208
[TBL] [Abstract][Full Text] [Related]
5. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the treatment of primary biliary cholangitis].
Li YM; Wang QX; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):805-809. PubMed ID: 29325272
[TBL] [Abstract][Full Text] [Related]
7. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
8. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
[TBL] [Abstract][Full Text] [Related]
9. From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.
Ronca V; Carbone M; Bernuzzi F; Malinverno F; Mousa HS; Gershwin ME; Invernizzi P
Expert Rev Clin Immunol; 2017 Dec; 13(12):1121-1131. PubMed ID: 28994348
[TBL] [Abstract][Full Text] [Related]
10. Immunological abnormalities in patients with primary biliary cholangitis.
Ma WT; Chen DK
Clin Sci (Lond); 2019 Mar; 133(6):741-760. PubMed ID: 30890652
[TBL] [Abstract][Full Text] [Related]
11. Cyr61 Alleviates Cholangitis by Inhibiting Cytotoxic Effects of CD8
Cheng TC; Li H; Luo X; Ju LL; Chen L; Shao JG; She YJ; Li M; Bian ZL
Curr Med Sci; 2021 Dec; 41(6):1205-1213. PubMed ID: 34787784
[TBL] [Abstract][Full Text] [Related]
12. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
[TBL] [Abstract][Full Text] [Related]
13. [Immune pathogenesis of primary biliary cholangitis].
Zhang MY; Zhao J; Xie H; Liang QS; Zou ZS; Sun Y
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):500-504. PubMed ID: 34225423
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of cholangiopathy in primary biliary cirrhosis.
Harada K; Nakanuma Y
Med Mol Morphol; 2006 Jun; 39(2):55-61. PubMed ID: 16821141
[TBL] [Abstract][Full Text] [Related]
15. Sequence of events leading to primary biliary cholangitis.
Lenci I; Carnì P; Milana M; Bicaj A; Signorello A; Baiocchi L
World J Gastroenterol; 2023 Oct; 29(37):5305-5312. PubMed ID: 37899786
[TBL] [Abstract][Full Text] [Related]
16. Investigational drugs in phase II clinical trials for primary biliary cholangitis.
Silveira MG; Lindor KD
Expert Opin Investig Drugs; 2017 Oct; 26(10):1115-1121. PubMed ID: 28836457
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
Graham RP; Smyrk TC; Zhang L
Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
[TBL] [Abstract][Full Text] [Related]
18. The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of biliary fibrosis.
Pinzani M; Luong TV
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1279-1283. PubMed ID: 28754450
[TBL] [Abstract][Full Text] [Related]
20. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
Bowlus CL; Kenney JT; Rice G; Navarro R
J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
